X-100650863-G-A

Variant summary

Our verdict is Likely benign. The variant received -6 ACMG points: 0P and 6B. BP4_ModerateBS2

The NM_014467.3(SRPX2):​c.161G>A​(p.Arg54Gln) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000449 in 1,202,969 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 24 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 15/23 in silico tools predict a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. R54R) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0000090 ( 0 hom., 0 hem., cov: 22)
Exomes 𝑓: 0.000049 ( 0 hom. 24 hem. )

Consequence

SRPX2
NM_014467.3 missense, splice_region

Scores

3
14
Splicing: ADA: 0.00005821
2

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:2

Conservation

PhyloP100: 0.267
Variant links:
Genes affected
SRPX2 (HGNC:30668): (sushi repeat containing protein X-linked 2) This gene encodes a secreted protein that contains three sushi repeat motifs. The encoded protein may play a role in the development of speech and language centers in the brain. This protein may also be involved in angiogenesis. Mutations in this gene are the cause of bilateral perisylvian polymicrogyria, rolandic epilepsy, speech dyspraxia and cognitive disability. [provided by RefSeq, May 2010]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -6 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.114234835).
BS2
High AC in GnomAdExome4 at 53 XLR,XL,AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SRPX2NM_014467.3 linkc.161G>A p.Arg54Gln missense_variant, splice_region_variant Exon 3 of 11 ENST00000373004.5 NP_055282.1 O60687

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SRPX2ENST00000373004.5 linkc.161G>A p.Arg54Gln missense_variant, splice_region_variant Exon 3 of 11 1 NM_014467.3 ENSP00000362095.3 O60687

Frequencies

GnomAD3 genomes
AF:
0.00000898
AC:
1
AN:
111387
Hom.:
0
Cov.:
22
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000286
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000383
AC:
7
AN:
182617
AF XY:
0.0000596
show subpopulations
Gnomad AFR exome
AF:
0.0000761
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000144
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000367
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000486
AC:
53
AN:
1091582
Hom.:
0
Cov.:
28
AF XY:
0.0000672
AC XY:
24
AN XY:
357106
show subpopulations
African (AFR)
AF:
0.0000762
AC:
2
AN:
26244
American (AMR)
AF:
0.00
AC:
0
AN:
35197
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19342
East Asian (EAS)
AF:
0.00142
AC:
43
AN:
30176
South Asian (SAS)
AF:
0.00
AC:
0
AN:
53912
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40359
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4093
European-Non Finnish (NFE)
AF:
0.00000837
AC:
7
AN:
836377
Other (OTH)
AF:
0.0000218
AC:
1
AN:
45882
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.477
Heterozygous variant carriers
0
2
3
5
6
8
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00000898
AC:
1
AN:
111387
Hom.:
0
Cov.:
22
AF XY:
0.00
AC XY:
0
AN XY:
33553
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
30626
American (AMR)
AF:
0.00
AC:
0
AN:
10527
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2639
East Asian (EAS)
AF:
0.000286
AC:
1
AN:
3500
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2590
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6020
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
237
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
53056
Other (OTH)
AF:
0.00
AC:
0
AN:
1506
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
0.0000868
Hom.:
1
Bravo
AF:
0.0000113
ExAC
AF:
0.0000330
AC:
4
EpiCase
AF:
0.00
EpiControl
AF:
0.0000594

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Uncertain:1
Feb 07, 2023
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.161G>A (p.R54Q) alteration is located in exon 3 (coding exon 2) of the SRPX2 gene. This alteration results from a G to A substitution at nucleotide position 161, causing the arginine (R) at amino acid position 54 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Rolandic epilepsy, intellectual disability, and speech dyspraxia, X-linked Uncertain:1
Nov 15, 2021
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 54 of the SRPX2 protein (p.Arg54Gln). This variant is present in population databases (rs761225832, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with SRPX2-related conditions. ClinVar contains an entry for this variant (Variation ID: 409283). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The glutamine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.096
BayesDel_addAF
Benign
-0.65
T
BayesDel_noAF
Benign
-0.91
CADD
Benign
13
DANN
Uncertain
0.99
DEOGEN2
Benign
0.053
T;.;.
FATHMM_MKL
Benign
0.36
N
LIST_S2
Benign
0.77
T;T;T
M_CAP
Uncertain
0.10
D
MetaRNN
Benign
0.11
T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.4
L;.;.
PhyloP100
0.27
PrimateAI
Benign
0.32
T
PROVEAN
Benign
-0.83
N;.;.
REVEL
Benign
0.048
Sift
Benign
0.13
T;.;.
Sift4G
Uncertain
0.035
D;.;.
Polyphen
0.0
B;.;.
Vest4
0.079
MutPred
0.45
Gain of phosphorylation at Y53 (P = 0.1452);Gain of phosphorylation at Y53 (P = 0.1452);Gain of phosphorylation at Y53 (P = 0.1452);
MVP
0.47
MPC
0.18
ClinPred
0.034
T
GERP RS
1.9
Varity_R
0.071
gMVP
0.40
Mutation Taster
=93/7
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000058
dbscSNV1_RF
Benign
0.042
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs761225832; hg19: chrX-99905860; COSMIC: COSV65934094; COSMIC: COSV65934094; API